| RS2107725932 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107726116 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107726546 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2107727475 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107728359 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107728809 |
SETD2
|
Health Risk |
Pathogenic |
— |
| RS2107729763 |
DOCK3
|
Health Risk |
Pathogenic |
— |
| RS2107729801 |
PTPN23
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity |
| RS2107730191 |
PTPN23
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS2107731142 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107732969 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107733058 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107735424 |
KY
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 7, Myofibrillar myopathy 7 |
| RS2107736723 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107738780 |
SETD2
|
Health Risk |
Likely pathogenic |
— |
| RS2107739635 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2107739850 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2107741719 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Transient bullous dermolysis of the newborn, Transient bullous dermolysis of the newborn |
| RS2107741763 |
SETD2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2107742434 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, 7 conditions |
| RS2107742867 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107743381 |
FOXL2
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Premature ovarian failure 3 |
| RS2107743526 |
FOXL2
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2107743541 |
FOXL2
|
Health Risk |
Pathogenic/Likely pathogenic |
Blepharophimosis, ptosis |
| RS2107744072 |
FOXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2107744367 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107744454 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2107744566 |
FOXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2107744774 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2107744913 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2107746826 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, 7 conditions |
| RS2107748182 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107748579 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2107749132 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107750137 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107755031 |
COL7A1
|
Health Risk |
Pathogenic |
Abnormality of the skin, Abnormality of the skin |
| RS2107756223 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107757088 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107757949 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107760251 |
COL7A1
|
Health Risk |
Pathogenic |
7 conditions, 7 conditions |
| RS2107760970 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107763474 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107763964 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107771861 |
COL7A1
|
Health Risk |
Likely pathogenic |
Transient bullous dermolysis of the newborn, Transient bullous dermolysis of the newborn |
| RS2107788093 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107788141 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107790996 |
COL7A1
|
Health Risk |
Likely pathogenic |
7 conditions, 7 conditions |
| RS2107793116 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107793500 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107793510 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107794257 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107795483 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107799999 |
COL7A1
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS2107801259 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107801858 |
COPB2
|
Health Risk |
Pathogenic |
Osteoporosis, childhood- or juvenile-onset |
| RS2107807665 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107807701 |
COPB2
|
Health Risk |
Pathogenic |
Osteoporosis, childhood- or juvenile-onset |
| RS2107807874 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107811815 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107812280 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107814279 |
STAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS2107821339 |
STAG1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2107821352 |
STAG1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2107823148 |
ROBO1
|
Health Risk |
Pathogenic |
Short stature, Short stature |
| RS2107830116 |
ZNF148
|
Health Risk |
Likely pathogenic |
— |
| RS2107831013 |
STAG1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2107831036 |
ZNF148
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS2107831883 |
ZNF148
|
Health Risk |
Likely pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS2107832092 |
ZNF148
|
Health Risk |
Pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS2107833567 |
ZNF148
|
Health Risk |
Likely pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS2107843274 |
UQCRC1
|
Health Risk |
Pathogenic |
Parkinsonism with polyneuropathy, Parkinsonism with polyneuropathy |
| RS2107905472 |
STAG1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS2107905668 |
STAG1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS2107907632 |
DBR1
|
Health Risk |
risk factor |
Encephalitis, acute |
| RS2107907650 |
DBR1
|
Health Risk |
risk factor |
Encephalitis, acute |
| RS2107921941 |
UBA5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS2107922089 |
UBA5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS2107925842 |
TF
|
Health Risk |
Likely pathogenic |
Atransferrinemia, Atransferrinemia |
| RS2107927490 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3A, Usher syndrome type 3A |
| RS2107927719 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Neuronal ceroid lipofuscinosis |
| RS2107927808 |
CLRN1
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2107927978 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS2107928969 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107929323 |
DAG1
|
Health Risk |
Likely pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS2107931458 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107932045 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107932226 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107932966 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 2, Glycine encephalopathy 2 |
| RS2107933731 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107933735 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107933839 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107935604 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS2107935989 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107937267 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107937292 |
UBA5
|
Health Risk |
Likely pathogenic |
— |
| RS2107937352 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 2 |
| RS2107937370 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107937536 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2107937574 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 2 |
| RS2107938475 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 2, Glycine encephalopathy 2 |